Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Fragments

Known as: Fragment 
 
National Institutes of Health

Related topics

Related topics

11 relations
Complement C3 fragment:MCnc:Pt:RBC:QnComplement C3 fragment:PrThr:Pt:RBC:OrdErythrocyte morphology finding:Prid:Pt:Bld:NomFc fragment Ab:ACnc:Pt:Ser:Qn
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Influence of Fragment Size and Postoperative Joint Congruency on Long-Term Outcome of Posterior Malleolar Fractures
Background: One of the factors contributing to long-term outcome of posterior malleolar fractures is the development of… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
2014
2014
A highly immunogenic fragment derived from Zaire Ebola virus glycoprotein elicits effective neutralizing antibody.
In order to produce polyvalent vaccines based on single rVSV vector, we investigated the immunogenicity, antibody neutralizing… Expand
  • figure 3
  • figure 4
  • figure 5
  • table 1
  • table 2
Highly Cited
2014
Highly Cited
2014
Two- and Three-dimensional Rings in Drugs
Using small, flat aromatic rings as components of fragments or molecules is a common practice in fragment‐based drug discovery… Expand
Highly Cited
2013
Highly Cited
2013
Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.
The identification of a novel series of small molecule BET inhibitors is described. Using crystallographic binding modes of an… Expand
  • figure 1
  • table 1
  • table 3
  • table 2
  • figure 2
2011
2011
Rainbow trout surviving infections of viral haemorrhagic septicemia virus (VHSV) show lasting antibodies to recombinant G protein fragments.
Rainbow trout antibodies (Abs) binding to recombinant fragments (frgs) derived from the protein G of the viral haemorrhagic… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Highly Cited
2004
Highly Cited
2004
A Mutant Ataxin-3 Putative-Cleavage Fragment in Brains of Machado-Joseph Disease Patients and Transgenic Mice Is Cytotoxic above a Critical Concentration
Machado-Joseph disease (MJD) is an inherited neurodegenerative disorder caused by ataxin-3 with a polyglutamine expansion. It is… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Highly Cited
2001
Highly Cited
2001
Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates.
Recent reports suggest that cells in active cell cycle have an engraftment defect compared with quiescent cells. We used nonhuman… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
1997
1997
Anti-CD3 epsilon F(ab')2 fragments inhibit T cell expansion in vivo during graft-versus-host disease or the primary immune response to nominal antigen.
This study was undertaken to distinguish between several mechanisms responsible for graft-vs-host disease (GVHD) protection in… Expand
1991
1991
Studies on Anti-von Willebrand Factor (vWF) Monoclonal Antibody NMC-4, Which Inhibits Both Ristocetin- and Botrocetin-Induced vWF Binding to Platelet Glycoprotein Ib
Anti-von Willebrand factor (vWF) monoclonal antibody NMC-4 completely inhibited vWF binding to platelet glycoprotein (GP) lb… Expand
1984
1984
EFFECT OF SIZE OF RADIOLABELED ANTIBODY AND FRAGMENTS ON TUMOR UPTAKE AND DISTRIBUTION IN NEPHRECTOMIZED MICE
The importance of molecular size in tumor (T) uptake of intact monoclonal antibody (MAb) or MAb fragments (frag.) is difficult to… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE